USA flag logo/image

An Official Website of the United States Government

THE GOAL OF THIS RESEARCH IS TO PRODUCE EFFECTIVE STABLE MICROEMULSIONS OF…

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
4838
Program Year/Program:
1986 / SBIR
Agency Tracking Number:
4838
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
California Biotechnology, Inc.
2450 Bayshore Parkway Mountain View, CA 94043
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1986
Title: THE GOAL OF THIS RESEARCH IS TO PRODUCE EFFECTIVE STABLE MICROEMULSIONS OF LIPOSOLUBLE VITAMINS FOR INTRAVENOUS DELIVERY.
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

THE GOAL OF THIS RESEARCH IS TO PRODUCE EFFECTIVE STABLE MICROEMULSIONS OF LIPOSOLUBLE VITAMINS FOR INTRAVENOUS DELIVERY. THE ADMINISTRATION OF FAT-SOLUBLE VITAMINS BECOMES A MEDICAL PROBLEM WHEN DEFICIENCIES IN THESE SUBSTANCES ARE DISPLAYED BY SUBJECTS WITH MALABSORPTION SYNDROME. LIPOSOLUBLE VITAMIN DEFICIENCY IN HUMANS IS MOST OFTEN ENCOUNTERED IN PREMATURE INFANTS AND IN ADULTS OR CHILDREN HAVING ABNORMAL ABSORPTION OF FATS FROM THE INTESTINE. ATTENTION HAS BEEN FOCUSED ON THE ADMINISTRATIONOF A-TOCOPHEROL DUE TO THE INCREASE IN THE NUMBER OF PRE- MATURE INFANTS IN THE PAST DECADE. ADMINISTRATION OF VITAMIN E IS PARTICULARLY IMPORTANT TO COUNTERBALANCE THE NEGATIVE EFFECT OF THE ADMINISTRATION OF OXYGEN TO THESE NEWBORNS. OXYGEN IS DIRECTLY BENEFICIAL IN TREATING INFANTSWITH HYALINE MEMBRANE DISEASE BUT HAS A SIDE EFFECT OF SEVERE DAMAGE TO THE RETINA. ADEQUATE LEVELS OF VITAMIN E CAN PREVENT THIS; HOWEVER, ORAL ADMINISTRATION OF VITAMIN E TO THESE INFANTS HAS CAUSED SEVERAL NEONATAL DEATHS. THE CURRENT PRODUCTS FOR SUCH PARENTERAL ADMINISTRATION ARE AQUEOUS EMULSIONS WHICH CONTAIN POLYSORBATES AS THE EMULSIFYING AGENT. IN CONTRAST TO THE CONVENTIONAL USE OF SYNTHETIC EMULSIFYING AGENTS, THIS RESEARCH WILL USE A NATURAL AMPHIPATHIC MOLECULE (PHOSPHOLIPID) TO SOLUBILIZE THOSE SUBSTANCES. THEREFORE, THE RESEARCH WILL FOCUS ON THEPREPARATION OF STABLE MICROEMULSIONS OF LIPOSOLUBLE VITAMIN E TO STUDY BLOOD TRANSPORT AND METABOLISM OF THE MICRO- EMULSIONS IN ANIMALS. THIS WORK IS CRITICAL TO THE PHASE IIRESEARCH, WHICH WILL FOCUS ON THE PREPARATION OF MULTI- VITAMIN MICROEMULSIONS AND HUMAN STUDIES.

Principal Investigator:

Jean-louis vigne
PRINCIPAL INVESTIGATOR
4159661550

Business Contact:

Small Business Information at Submission:

California Biotechnology Inc
2450 Bayshore Frontage Road Mountain View, CA 94043

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No